Trial Profile
Effects of alosetron versus traditional therapy on healthcare resource use, productivity, and quality of life in female patients with diarrhoea-predominant irritable bowel syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2011
Price :
$35
*
At a glance
- Drugs Alosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 21 Feb 2011 New trial record